Thames Valley Cytology Society

Volume 5 Issue 1
January 2002

 

A Collection Fluid Optimising FNA Processing

Report by Lauri Clarke, London Hospital

 

At TVCS meeting 10th November 2001 at Watford general Hospital, Veda Misir (BMS2 at the Royal Glamorgan Hospital, Wales) gave a clear and concise talk about the Fine Needle Aspiration (FNA) procedure and a simple FNA collection fluid that is compatible with Liquid Based Cytology (LBC) technology.

The technical goal of the FNA procedure is to ensure that every diagnostic cell aspirated reaches the pathologist in optimal condition for microscopic examination. Smear quality, together with obtaining a representative sample and the experience of the pathologist plays a critical role in this procedure. Technical problems that can effect smear quality are that diagnostic cells may be trapped in needle clots, unrepresentative material can lead to inaccuracy and in smear preparation there may be crush artefact, inadequate fixation of "wet" smears or diagnostic cells obscured by blood or exudate.

Attempts to address smear quality include

  • improved training of clinicians in smear preparation,
  • attendance at FNA by technical staff and
  • use of collection fluids.

The advantages of using a collecting fluid

  • each slide is representative of the aspirate so accurate rapid evaluation is possible,
  • delayed optimal processing in lab is facilitated,
  • cell retrieval is maximised through needle rinse,
  • there is no need for technical staff attendance,
  • there is no need for clinical skill in smear preparation
  • health and safety issues are addressed.


The qualities of an ideal collecting fluid

  • cellular integrity and morphology must be preserved,
  • routine stains facilitated,
  • any smear processing system facilitated (direct smear, cytospin, TLC),
  • allows at least 60 hours storage,
  • facilitate ancillary techniques (eg Immunocytochemistry)
  • must be cheap, easily stored and disposed of.

Existing fluids include alcoholic fluids that are excellent for Pap but not for Giemsa, and non-alcoholic ones that make Pap and Giemsa stains possible.
These latter include normal saline, RMPI culture medium(not compatible with Thin Prep processor), and balanced electrolyte solutions (BES).

The BES are saline base eg Normosol or Plasmalyte and are cheap, easily available commercially, are used intravenously so kind to cells and the aspirate in BES is similar to native material so can be treated like a fluid such as CSF.

ThinPrep (TP) was introduced, at the Royal Gwent Hospital (RGH), for non-gynae work and although the TP Paps were good there was disappointment at the lack of TP/Giemsa facility. With the added problem that no technical staff were available to attend FNAs, a pilot study was set up using transport solutions compatible with conventional staining and the TP processor, with the aim to provide a single fluid to facilitate both TP Pap and conventional Giemsa and ensure rapid evaluation on representative material.

This pilot study used Plasmacyte (BES) in 2.0ml aliquots in universals, stored at 4 C and carried out on serous fluid deposits and fresh, unfixed, resected tumours.

The results were excellent staining and preparations for TP Pap, Cytospin Giemsa/Pap, direct Giemsa, Pap, H&E and Immunocytochemistry.

The main study was carried out in collaboration with the Radiology Dept at RGH. It took the form of a Split Sample Study allowing comparison of conventional direct smears and Plasmalyte smears. The organs examined included breast, liver, thyroid, lymph node and lung from which there were 47 adequate samples. Features examined were nuclear/cytoplasmic detail, architecture and background material.

For conventional preps at least two direct smears were taken - one air dried Giemsa and one wet fixed for Pap/rapid H&E. For Plasmacyte preps - the remaining material, including the needle rinse was placed in a Plasmacyte aliquot and processed to give - one Giemsa Cytospin (low speed using Shandon Megafunnel) and one TP Pap.

The main study results were based on adequate Plasmacyte samples. High quality TP/Pap and Giemsa smears were produced, cells are concentrated so easier to screen, Giemsa and TP Pap complement each other, there is rapid evaluation of adequacy, ancillary studies are facilitated and storage is possible up to 60 hours at 4 C.

The concusion of this study is that Plasmalyte, an intravenous saline solution, easily available from hospital pharmacies is an ideal collection fluid for optimising FNA processing.